Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y. Wen, Martin J. van den Bent, Timothy F. Cloughesy et al.|Neuro-Oncology|2020Cited by 1.1k
Response assessment criteria for brain metastases: proposal from the RANO groupNancy U. Lin, Patrick Y. Wen, Eudocia Q. Lee et al.|The Lancet Oncology|2015Cited by 1.1k
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patientsEudocia Q. Lee, Patrick Y. Wen, Michael Weller et al.|Neuro-Oncology|2020Cited by 40
Multimodal platform for assessing drug distribution and response in clinical trialsBegoña Giménez, Nathalie Y.R. Agar, Ishwar N. Kohale et al.|Neuro-Oncology|2021Cited by 14
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVerónica Rendo, Rameen Beroukhim, Eudocia Q. Lee et al.|Science Translational Medicine|2025Cited by 13